AMICUS THERAPEUTICS INC COM STK USD0.01 financial statements, including revenue, expenses, profit, and loss

The total revenue of 0HF9 for the last quarter is 110.40 M USD, and it's 4.07% lower compared to the previous quarter. The net income of Q1 24 is -48.42 M USD.